Drugs / PRS-344/S095012
last change Apr 2025 re-read 2 minutes ago

PRS-344/S095012

Developed for
cancer
Investigated by
Servier · Servier Bio-Innovation LLC

Trials 1 · a red edge is where a trial was stopped

20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT05159388 Sep 2021 → Apr 2025 cancer Servier Bio-Innovation LLC Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as PRS-344/S095012 ClinicalTrials.gov intervention name — accepted as the source's own label NCT05159388